Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, today announced FDA approval of a Phase II clinical trial ...

Atherosclerosis is characterized by lipid deposition and chronic inflammation, associated with immune activation and the induction of inflammatory mediators and signalling pathways Putative ...

A randomized controlled trial compared coronary artery plaque progression after androgen deprivation therapy using relugolix vs leuprolide in men with prostate cancer.

This study explores the role of methoxy polyethylene glycol@Elabela-11 (mPEG@ELA-11), a pH-responsive ELA-11 conjugate, in ...

Researchers have shown in a new study on mice, that cell therapy can be used to reverse the effect of "bad" LDL cholesterol and reduce the inflammation that leads to atherosclerosis. The new cell ...

How can we slow down atherosclerosis? Researcher Amanda Foks believes it may be possible by switching off ageing immune cells ...

Dyslipidemia refers to lipoprotein disorders detected by laboratory tests, and usually occur without signs or symptoms during childhood and young adult age. Proper recognition and management of ...

For atherosclerosis patients who experience a wide range of side effects to cholesterol-lowering drugs, an alternate option would be life-changing. Although stemming from less than normal means, ...

Medical illustration showing how plaque buildup and clot formation can restrict blood flow in arteries. Researchers have developed a luteolin-based nanomedicine that targets and stabilizes these ...

The atherosclerotic process starts in childhood and studies show its development in fetuses. Clinical manifestation often occurs only in the sixth decade of life. Adolescence is a critical period in ...

Researchers at Karolinska Institutet have shown in a new study on mice, that cell therapy can be used to reverse the effect of 'bad' LDL cholesterol and reduce the inflammation that leads to ...